Related Experiment Video
Updated: Jul 19, 2026
08:48
Peptide-derived Method to Transport Genes and Proteins Across Cellular and Organellar Barriers in Plants
Published on: December 16, 2016
Thermally associating polypeptides designed for drug delivery produced by genetically engineered cells
David S Hart1, Stevin H Gehrke
1Department of Chemical and Petroleum Engineering, The University of Kansas, 1530 W 15th St., Lawrence, Kansas 66045, USA.
Journal of Pharmaceutical Sciences
|November 3, 2006
Summary
Novel thermally associating artificial proteins, developed through genetic engineering, offer advanced pharmaceutical applications. These biomaterials provide new solutions for drug delivery and production processes.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Pharmaceutical Technology
Background:
- Thermally associating polymers like gelatin have long been used in pharmacy.
- Advances in genetic engineering enable the creation of novel polypeptides with unique properties.
Purpose of the Study:
- To review the development and characterization of thermally associating artificial proteins.
- To examine the pharmaceutical applications of these novel biomaterials.
Main Methods:
- Focus on polypeptides derived from elastin, silk, and coiled-coil helices.
- Review of materials expressed in recombinant cells.
- Characterization of thermally associating properties.
Main Results:
- Designed polypeptides exhibit thermally associating behavior.
- These artificial proteins offer advantages over current materials.
- Potential applications include drug delivery systems and simplified production.
Conclusions:
- Thermally associating artificial proteins represent a novel class of biomaterials.
- They hold significant potential for diverse pharmaceutical applications.
- Further research can optimize their use in drug formulation and manufacturing.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...